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Abstract
Background—Although cerebral lesions ≥3mm on imaging are associated with incident stroke, 
lesions < 3mm are typically ignored.
Objective—To examine stroke risks associated with subclinical brain lesions by size (< 3 mm 
only, lesions ≥3 mm only, both < 3 mm and ≥3 mm) and white matter hyperintensities (WMH).
Design—Community cohort, Atherosclerosis Risk in Communities (ARIC) Study
Setting—Two ARIC sites with magnetic resonance imaging (MRI) data (1993–95)
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Participants—1,884 (99%) adults (50–73 years, 40% men; 50% black) with MRI and no prior 
stroke; average 14.5 years follow-up.
Measurements—MRI lesions: none (n=1611), < 3 mm only (n=50), ≥3 mm only (n=185), or 
both < 3 and ≥3 mm lesions (n=35); WMH score (0–9 scale). Outcomes: incident stroke (n=157), 
overall mortality (n=576), stroke mortality (n=50). Hazard Ratios (HR) estimated with 
proportional hazards models.
Results—Compared to no lesions, stroke risk was tripled with lesions < 3mm only (HR=3.47, 
95% CI:1.86-6.49), doubled with lesions ≥3 mm only (HR=1.94, 95% CI:1.22-3.07), and was 8-
fold higher with both < 3 mm and ≥3 mm-sized lesions (HR=8.59, 95% CI:4.69-15.73). Stroke 
risk doubled with WMH ≥3 (HR=2.14, 95% CI:1.45-3.16). Stroke mortality risk tripled with 
lesions < 3 mm only (HR=3.05, 95% CI:1.04-8.94), doubled with lesions ≥3 mm (HR=1.9, 95% 
CI:1.48-2.44) and was seven-times higher with both lesion sizes (HR=6.97, 95% CI:2.03-23.93).
Limitations—Few stroke events (n=147), especially hemorrhagic (n=15); limited numbers of 
participants with only lesions ≤3mm (n=50) or with both lesions ≤3mm and 3–20mm (n=35).
Conclusions—Very small cerebrovascular lesions may be associated with increased risks of 
stroke and mortality; having both < 3 mm and ≥3 mm lesions may represent a particularly striking 
risk increase. Larger studies are needed to confirm findings and provide more precise estimates.
Introduction
Subclinical brain infarcts (SBI) are standardly defined as lesions > 3 mm on brain imaging 
(1, 2) in persons with no history of clinical stroke, and both SBI and white matter 
hyperintensities (WMH) have been associated with increased risk of stroke and mortality, 
mainly in older people.(3–14) Brain structural abnormalities may be objective markers of 
stroke risk, yet lesions < 3 mm are typically ignored in clinical and research settings due to 
potential misclassification of presumed non-vascular lesions, such as Virchow-Robin spaces, 
as vascular lesions, and lack of data regarding associations with outcomes. However, even 
very small lesions may be mediated through vascular processes such as infarcts, 
leukoaraiosis, and endothelial dysfunction;(15–18) the STRIVE consortium recently 
included small lesions, including potential perivascular spaces as a possible form of cerebral 
small vessel disease.(18) The relationship of lesions < 3mm to important clinical outcomes 
is unknown. If even very small lesions < 3mm are associated with stroke and mortality, 
these may identify at-risk persons early on and in whom targeted preventive measures may 
be warranted.
Ethnic minorities, including non-Hispanic blacks, are more likely than their white 
counterparts to suffer strokes, strokes at earlier ages, stroke-related disability, and stroke 
deaths.(19),(20) Yet, most studies of brain structural abnormalities and stroke risk have been 
in older and primarily white populations.(5, 6, 10, 13, 14, 21) Increased stroke risk 
associated with brain vascular lesions has been observed in the younger Framingham 
Offspring cohort,(6) as have increased stroke and mortality in a middle-to-older aged 
Japanese population(4) but studies in middle-aged persons and minorities including blacks 
are limited. Identifying early markers of at-risk individuals could significantly impact the 
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public health burden of cerebrovascular disease in all ethnic groups, given associations with 
cognitive decline/dementia, gait impairment, and stroke.(13, 22–26)
The purpose of this study was to examine the associations of incident stroke, stroke-related 
mortality, and all-cause mortality with SBI lesions < 3mm, lesions ≥3mm, the combination 
of < 3mm and ≥3mm-sized lesions, and WMH in a middle-aged biracial population.
METHODS
Population
The ARIC study cohort has been previously described.(27) Participants ≥55 years from 
Forsyth County, NC and Jackson, MS were invited to undergo brain magnetic resonance 
imaging (MRI) at ARIC visit 3 (1993–95, n=2,892). Of these, 103 were ineligible for safety 
reasons; 654 refused; 122 did not initially refuse but did not undergo MRI exam; 73 
attempted but did not complete and 6 completed MRI forms but had no data. (Online 
Appendix Figure 1) Participants who underwent MRI were older 62 vs 59 years) but 
otherwise similar to those without MRI. (Online Appendix Table 1) We obtained MRI data 
on 1,934 participants, excluded 46 with prevalent strokes and four who reported non-white, 
non-black ethnicity, leaving 1,884 for this analysis. Institutional Review Boards approved 
study protocols; all participants provided informed consent.
Brain Imaging
Protocols for brain MRI have been described in detail and were identical to those used in the 
Cardiovascular Health Study (CHS).(28, 29) Briefly, 5 mm contiguous axial whole brain T1, 
T2, and proton density weighted images were obtained using 1.5-T scanners. SBI were 
defined by shape, absence of mass effect, and hyperintensity to gray matter on proton 
density and T2-weighted images, in contrast to perivascular spaces which demonstrate 
intensity similar to cerebrospinal fluid and show typical locations and morphology.(30) SBI 
within cerebral white matter were also required to be hypointense on T1-weighted images. 
The maximal right-to-left and anterior-to-posterior lesions dimensions were recorded with 
an electronic cursor. The superior-to-inferior dimension was reported by the number of 5 
mm axial sections on which the lesion appeared. Lesions < 3 mm on right-to-left or anterior-
to-posterior measurements were recorded as “less than 3 mm.”(28, 31) Images were double 
read independently by two neuroradiologists and discrepant cases were adjudicated by 
consensus among three or more readers.
We included cortical and non-cortical lesions. Lacunes were defined as non-cortical lesions 
3–20 mm in the basal ganglia, brain stem, thalamus, internal capsule, or cerebral white 
matter. Non-lacunar lesions were 3–20 mm lesions outside these areas or > 20 mm in any 
area on right-to-left or anterior-to-posterior measurements. The number of lesions < 3 mm 
were recorded as 0, 1–2, or > 2, and lesions ≥3 mm were recorded as 0, 1, or ≥2 (up to 5).
(28, 31)
Periventricular and subcortical WMH were graded on a scale from 0 (no white matter signal 
abnormalities) to 9 (extensive confluent white matter involvement), based on pattern 
matching to a set of reference standards.(29, 32)
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Incident Stroke and Mortality Ascertainment and Criteria
Adjudicated nonfatal and fatal hospitalized clinical strokes were identified through yearly 
phone interviews and surveillance methods that additionally included hospital record 
reviews and medical chart abstraction.(33) Deaths were identified through contacts with 
next of kin, hospital records, state death records, and the National Death Index. Stroke 
mortality was adjudicated by expert stroke reviewers. Follow-up was complete through 
2010.
Stroke was defined based on the National Survey of Stroke criteria and required evidence of 
sudden or rapid onset of neurological symptoms that persisted for > 24 hours or led to death 
with no other apparent cause such as trauma, tumor, infection, or anticoagulation therapy.(7, 
33, 34) Of hospitalized strokes, 99% underwent a diagnostic CT or MRI.(7) Symptoms plus 
acute infarctions or absence of hemorrhage on imaging defined ischemic strokes. 
Hemorrhagic strokes met 1 of the following criteria: (1) CT or MRI with intraparenchymal 
hematoma; (2) demonstration at autopsy or surgery; or (3) at least 1 major or 2 minor 
neurological deficits; a bloody spinal fluid on lumbar puncture; and no CT or MRI, with or 
without cerebral angiography demonstrating an avascular mass effect and no evidence of 
aneurysm or arteriovenous malformation.(7, 21, 33)
Covariates
All covariates were measured at ARIC Visit 3 when the MRI was conducted. Body mass 
index (BMI) was calculated as kilograms/meters2. Hypertension was defined as systolic 
blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or use of antihypertensive 
medication during the past 2 weeks. Diabetes mellitus was defined as a fasting blood 
glucose ≥ 126 mg/dL, nonfasting blood glucose > 200 mg/dL, antidiabetic medication use 
during the past two weeks, or a physician diagnosis of diabetes. Standardized questionnaires 
were used to ascertain medical history, smoking, and alcohol consumption. Smoking and 
alcohol status were categorized as never, former, or current. Educational attainment was 
categorized as < 12 years, 12–16 years, > 16 years. Additional covariates from the 
Framingham Stroke Risk Factors were not included due to reductions in the sample size and 
low prevalence (e.g. atrial fibrillation < 1% [n=4] and LVH 4% [n=78]).
Data Analysis
Associations of participant characteristics with lesion types (no lesions, lesions < 3mm only, 
lesions ≥3 mm only, and both < 3 mm and ≥3 mm lesions) were examined using Fisher’s 
exact tests, Kruskal-Wallis tests and multinomial regression to estimate relative risk ratios 
(RRR).
Cumulative incidence curves show incidence of stroke and stroke mortality outcomes over 
time by lesion type and WMH (standardized curves are provided in the online Appendix 
Figure 2). Cox proportional hazard models were used to estimate hazard ratios (HR) for 
associations of MRI predictors with adjudicated event outcomes (incident stroke, stroke 
subtype, all-cause mortality, and stroke-mortality). We examined the associations of having 
none vs. very small only (< 3mm) vs. larger only (≥3mm) vs. both (< 3mm and ≥3mm) 
lesion types in a single model. We then examined presence of very small lesions and 
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numbers of very small lesions (dose-response effects) in separate models (e.g. associations 
of having very small lesions regardless of larger lesion presence), in order to preserve cell 
sizes when examining numbers of lesions. Presence of larger lesions, lacunar\non-lacunar 
infarcts, and number of lacunar infarcts were similarly examined in separate models, again 
to preserve cell sizes. WMH was examined using ordinal WMH (grade 0–9) and 
dichotomous WMH (grade < 3 vs. ≥3).(14, 29)
Models were adjusted for a priori chosen covariates including age, sex, a 3-level race–center 
variable (black–Forsyth, black–Jackson, white–Forsyth), education, BMI, smoking, alcohol 
use, diabetes, systolic and diastolic blood pressure, hypertension medications, heart disease, 
statins, high-density lipoprotein and low-density lipoprotein (LDL) cholesterol, and 
triglycerides. Alternative adjustment models (including only the first three, four and seven 
adjustors) provided quantitatively similar results with the same conclusions, as did 
additional adjustments for aspirin use; unadjusted models provided the same conclusions 
with larger effect sizes. Proportional hazards assumptions did not appear violated via 
diagnostic log-log-survival plots and Schoenfeld residual tests (p=0.692 for stroke). Effect 
modifications by sex, race, and age were unsupported. Stata version 13 (StataCorp LP, 
College Station, TX) was used.
Role of the Funding Source
The funding sources had no role in the design and conduct of the study; collection, 
management, analysis, and interpretation of the data; preparation, review, or approval of the 
manuscript; and decision to submit the manuscript for publication.
RESULTS
Over an average follow-up of 14.5 years, there were 157 clinical strokes, 50 stroke-related 
deaths, and 576 all-cause deaths. Among those without stroke events, 90% had over 10 years 
of follow-up.
Table 1 shows the visit 3 population characteristics (50% black, 60% women, and median 
age 63 [range 50–73]), stratified by presence and size of lesion. A majority of participants 
(64%) were < 65 years at the MRI exam. Lesion type (< 3 mm only, ≥3 mm only, or both) 
was associated with typical cerebrovascular disease risk factors, including older age, black 
race, lower education, smoking, diabetes, hypertension, hypertension medication, systolic 
and diastolic blood pressure, and alcohol.
Risk of Stroke, All-cause Mortality, and Stroke-Mortality by Lesion Size
Most strokes (89%) were ischemic, with similar estimates reported for any stroke and 
ischemic stroke. Cumulative incidence curves associated with lesion size are shown in 
Figure 1 A-B and adjusted hazard ratios (HR) in Table 2. Lesions < 3 mm only were 
associated with a three-fold increased risk of incident stroke (HR=3.47, 95% CI: 1.86, 6.49) 
compared to no lesions as were lesions ≥3 mm only (HR=1.94, 95% CI: 1.22, 3.07). Having 
both lesion sizes, < 3 mm and ≥3 mm, was associated with a nearly nine-fold increased risk 
of incident stroke (HR=8.59, 95% CI: 4.69, 15.73). Lesions < 3 mm only (HR=17.25, 95% 
CI: 4.05, 73.46) and having both lesions < 3 mm and ≥3 mm (HR=26.67, 95% CI: 5.21, 
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136.46) were associated with increased risk of hemorrhagic stroke (Table 2), although 
estimates were less precise due to infrequent events.
Lesions < 3 mm were associated with a three-fold increased risk of stroke-mortality 
(HR=3.05, 95% CI: 1.04-8.94), but not all-cause mortality (HR=1.34, 95% CI: 0.84, 2.13). 
Conversely, lesions ≥3 mm were associated with a nearly two-fold increased risk of all-
cause mortality (HR=1.90, 95% CI: 1.48, 2.44) but were not statistically associated with risk 
of stroke-mortality (HR=1.87, 95% CI: 0.83, 4.23). The presence of both lesion sizes was 
associated with increased risk of stroke mortality (HR=6.97, 95% CI: 2.03, 23.93) and all-
cause mortality (HR=1.89, 95% CI: 1.14, 3.13). (Table 2
Risk of Stroke, All-cause Mortality, and Stroke-Mortality by Presence and Number of 
Lesions < 3 mm
Having any lesion < 3 mm, including concomitant lesions ≥3mm, was associated with 
increased risk of any stroke (HR=4.94, 95% CI: 3.08, 7.92), stroke mortality (HR=5.14, 
95% CI: 2.08, 12.73) and all-cause mortality (HR=1.49, 95% CI: 1.04, 2.13). (Table 2) The 
presence of 1–2 lesions < 3 mm versus no lesions conveyed an approximate 5-fold increased 
risk of stroke (HR=4.87, 95% CI: 2.99, 7.93) and stroke mortality (HR=5.87, 95% CI: 2.33, 
14.78). Having more than 2 lesions < 3 mm in size was similarly associated with a more 
than 5-fold increased risk of stroke (HR= 5.72, 95% CI: 1.64, 19.94). (Table 2) Stroke-
mortality events were too rare to estimate relationships.
Risk of Stroke, All-cause and Stroke Mortality by Presence and Number of Lesions ≥3 mm
The presence of any lesion ≥3 mm was associated with an increased risk of incident stroke 
(HR=2.54, 95% CI: 1.70-3.79), with similar results when limited to non-lacunes (HR=4.92, 
95% CI: 2.31, 10.49) or lacunes (HR=2.30, 95% CI: 1.49, 3.55). (Table 2) Having only one 
versus no lacunes was associated with an almost two-fold increased risk of stroke (HR=1.81, 
95% CI: 1.06, 3.08) while having two or more lacunes was associated with a nearly four-
fold risk of stroke (HR=3.64, 95% CI: 1.98, 6.69).
Similar associations were found between any lesions ≥3 mm and ischemic and hemorrhagic 
stroke (HR= 2.35, 95% CI: 1.54, 3.60; HR=6.42, 95% CI: 1.68, 24.44). (Table 2) Lacunes 
and non-lacunes were associated with risk of ischemic and hemorrhagic stroke. The data 
were also suggestive of a dose response when considering ischemic stroke risk and number 
of lacunes versus no lesions (1 lacune: HR=1.83, 95% CI: 1.05, 3.16; ≥2 lacunes: HR=2.58, 
95% CI: 1.26, 5.28).
The presence of any lesion ≥3 mm was associated with stroke mortality (HR=2.63, 95% CI: 
1.25, 5.52) and all-cause mortality (HR=1.88, 95% CI: 1.48, 2.37). Similarly, lacunes were 
associated with a three-fold increased risk of stroke mortality (HR=3.33, 95% CI: 1.57, 
7.05), and nearly two-fold increased risk of all-cause mortality (HR=1.69, 95% CI: 1.31, 
2.17); greater numbers of lacunes were associated with all-cause mortality (1 lacune: 
HR=1.47, 95% CI: 1.09, 1.98; ≥2 lacunes: HR=2.36, 95% CI: 1.59, 3.50), while ≥2 lacunes 
was associated with stroke mortality (1 lacune: HR=1.94, 95% CI: 0.78, 4.86; ≥2 lacunes: 
HR=11.71, 95% CI: 4.10, 33.47). Non-lacunes were also associated with all-cause mortality 
(HR=3.90, 95% CI: 2.35, 6.46). (Table 2)
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Risk of Stroke, All-cause Mortality, and Stroke-Mortality by WMH
WMH were associated with incident stroke as an ordinal (0–9 scale, HR=1.30 per unit, 95% 
CI: 1.15, 1.46) and categorical (0–3 vs ≥3, HR=2.14, 95% CI: 1.45, 3.16) variable. (Table 2) 
The ordinal and categorical WMH were also associated with all-cause mortality (HR=1.20 
per unit, 95% CI: 1.12, 1.29; HR=1.78, 95% CI: 1.42, 2.23) and stroke mortality (HR=1.35 
per unit, 95% CI: 1.10, 1.66; HR=2.47, 95% CI: 1.25, 4.87).
Risk Factors of Lesion Occurrence
The primary characteristic associated with having only very small lesions (< 3mm) was 
hypertension (RRR=2.17, 95%CI: 1.14, 4.13) (Table 3). Having only larger lesions (≥3mm), 
was associated with hypertension (RRR=1.71, 95%CI: 1.20, 2.43) as well as older age, black 
race and current smoking status. Consistent with established risk factors of cerebrovascular 
disease (10, 13, 22), older age, black race, smoking, and hypertension (RRR=6.01, 95%CI: 
2.01, 17.99), were associated with having both lesion sizes, while higher education was 
protective. Interaction terms between lesions or WMH and sex, race, or age in separate 
models did not support differential relationships between MRI abnormalities and stroke/
mortality outcomes though sample sizes were limited for effect modification investigations.
DISCUSSION
Our study demonstrates that, among asymptomatic middle-aged to older persons with no 
history of clinical stroke, even very small lesions in the brain were associated with risks of 
future stroke and mortality, similar to lesions of typical clinically-defined size thresholds (3–
20mm), as were WMH in both white and black participants. Risk was greater if both sized 
lesions, i.e. < 3mm and those 3–20 mm, were present, even after adjusting for many 
potential confounders.
Although clinicians and researchers tend to be dismissive of very small cerebral lesions, the 
current findings provide evidence that this practice could warrant reconsideration. It is 
unclear if lesions of this size represent vascular pathology or perhaps dilated perivascular 
spaces called Virchow-Robin spaces.(30) However, even perivascular spaces are 
increasingly recognized as potentially pathologic. Lesions of presumed vascular origin and 
perivascular spaces share similar risk profiles, and perivascular spaces are associated with 
cerebral small vessel disease severity,(15–17) stroke and cognitive decline,(35) WMH(36, 
37) and symptomatic lacunar infarcts,(16, 36) in support of a vascular pathology. In this 
study, expert neuroradiologists used a standard protocol and were aware of distinctions 
between infarcts and perivascular spaces (e.g. location, shape, intensity). Although we have 
high confidence in our classification of perivascular spaces versus silent infarcts, we 
acknowledge the distinction becomes more difficult for infarcts < 3mm since signal intensity 
becomes more subject to partial voluming (the lesion is small relative to the slice or pixel 
volume) and the morphology becomes more difficult to characterize. However, perivascular 
spaces are now largely considered a form of vascular disease, potentially due to endothelial 
dysfunction.(18) Regardless of etiology of the lesions, our study demonstrates increased risk 
for stroke and mortality associated with even the very small lesions, adding to a growing 
corpus of literature supporting associations between very small lesions and cardiovascular 
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risk factors (31), clinical disease including atrial fibrillation,(38) and now, stroke and 
mortality.
Smaller cerebrovascular lacunar lesions (typically defined as up to 7mm) and larger 
(typically 5–20mm) lacunar lesions are thought to be pathogenically and clinically different, 
with the smaller ones developing from lipohyalinosis and potentially endothelial dysfunction 
(18) while the larger ones are more likely to be symptomatic and due to microatheromatous 
disease.(1) Our robust associations of lesions < 3mm with stroke and stroke mortality 
support the hypothesis that very small lesions are pathologic and of clinical importance; we 
extend previous work in the ARIC cohort which identified diabetes and hemoglobin A1C 
levels as risk factors for lesions < 7 mm, while lesions > 7 were associated with LDL 
cholesterol,(31) consistent with Fisher’s hypothesis(1) and previous studies on risk factors 
for silent lesions in the brain.(2, 21, 22, 32, 39) Our study extends these findings by 
examining lesions < 3mm separately from those ≤7mm. The most robust association of a 
risk factor with lesions < 3mm was hypertension followed by age and black race, all of 
which are well-known risk factors for stroke and cardiovascular disease.(2, 22, 29) The 
associations with cardiovascular risk factors further support the hypothesis that these lesions 
represent early microvascular disease.
Associations with stroke appear stronger for lesions < 3mm than for larger lesions. There are 
several potential explanations for this findings. First, the events were few with overlapping 
confidence intervals for lesions < 3mm and those > 3mm, so the true association could also 
be smaller or similar to lesions > 3mm. Larger lesions could have led to strokes, resulting in 
deaths, drop-outs, or exclusion from the analysis due to prevalent stroke. However, persons 
with strokes at the baseline visit were excluded and deaths or loss-to-follow-up due to 
strokes seems unlikely since the follow-up was extremely high.
Our data supported a dose response mechanism which adds support for causal associations; 
risk for stroke and mortality was increased with either size lesion but was highest among 
those with both sized lesions and no other brain abnormalities (HR=14.76, 95% CI: 6.29, 
34.60; Appendix Table 2). Furthermore, stroke risk increased with increasing numbers of 
lesions, regardless of lesion type. These findings are especially timely given evidence that 
statins may prevent incident subclinical infarcts.(40) Future studies are needed to examine 
the impact of preventive treatment in asymptomatic persons, including those with even the 
smallest abnormalities.
Strengths of this study include a middle-aged cohort at baseline with a large representation 
of African Americans, standardized measures of MRI lesions, and a validated ascertainment 
of incident stroke and stroke subtypes. Limitations included the infrequent events, 
particularly hemorrhagic stroke (n=15) and stroke-mortality (n=50) events. Despite these 
small samples, strong associations were observed. Studies with larger numbers of stroke 
events are needed to provide more stable and precise estimates of the relative risks 
associated with very small lesions. Use of 1.5T MRI and potential misclassification of 
lesions < 3mm due to lower pixel resolution may be considered limitations as higher 
resolution imaging is now available; this was not available at visit 3. We expect most 
misclassification of lesions < 3mm to result in non-infarcts being labeled as infarcts and bias 
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results to null findings. Thus, we believe our findings are conservative. Newer high 
definition imaging might improve classification of lesions < 3 mm and should be examined 
in future studies to confirm our results. Although recent recommendations consider lesions 
of presumed vascular origin to be 3–15mm in size,(30) we used an established definition of 
3–20mm at the time of this study. However, the focus of this paper was on risk associated 
with lesions < 3mm and the definition used is consistent with previous studies.(2, 12, 29, 41)
In conclusion, we found that middle-aged and older black and white adults with lesions < 3 
mm only and lesions ≥3 mm only, as well as WMH, may be at heightened risk for incident 
stroke and mortality. The simultaneous presentation of both < 3mm and ≥3mm lesions may 
represent a particularly marked increase in risk. Larger studies are needed to confirm these 
findings, provide more precise estimates, and investigate physiologic pathways.
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Appendix Figure 1. 
Study Flow Diagram
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Appendix Figure 2. Standardized Cumulative Hazards of stroke and stroke mortality by lesion 
size and white matter hyperintensity (WMH) grade
(Figures shown with conditional standardization based on adjustor variables in primary 
models reported in Table 2 set at mean and mode values for continuous/categorical variables 
respectively. Results are similar to those shown in the unadjusted KM plots in Figure 1).
Appendix Table 1
Comparison of Visit 3 Characteristics between those 
with MRI (N=4,035), those without MRI (N=1,935) at 
the Forsyth and Jackson ARIC sites, as well as those 
included in the current study (N=1,884/1,934)
Characteristics were similar in general with the exception of age; participants with 











Age (yrs) 59.71 (5.83) 58.43 (5.96) 62.39 (4.50) 62.37 (4.50)
Male (%) 3495 (59%) 2342 (58%) 1153 (60%) 1132 (60%)
Black (%) 2469 (41%) 1693 (42%) 776 (40%) 747 (40%)
BMI (m/kg2) 3009 (50%) 2040 (51%) 969 (50%) 945 (50%)
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Smoker (%) 2955 (50%) 1995 (49%) 960 (50%) 934 (50%)
Diabetes (%) 28.61 (5.90) 28.90 (6.18) 28.01 (5.19) 27.98 (5.21)
HTN (%) 4687 (79%) 3118 (78%) 1569 (82%) 1530 (82%)
HTN Meds (%) 1238 (21%) 885 (22%) 353 (18%) 342 (18%)
Prev CHD (%) 4820 (82%) 3255 (82%) 1565 (82%) 1539 (83%)
Tot Chol (SI) 1085 (18%) 735 (18%) 350 (18%) 326 (17%)
HDL (SI) 3165 (53%) 2187 (54%) 978 (51%) 967 (52%)
Trigs (SI) 2772 (47%) 1834 (46%) 938 (49%) 900 (48%)
Statin Med (%) 3485 (58%) 2394 (59%) 1091 (57%) 1077 (57%)
Never Drinker 2479 (42%) 1641 (41%) 838 (43%) 802 (43%)
Former Drinker 5474 (94%) 3704 (93%) 1770 (94%) 1733 (94%)
Current Drinker 378 (6%) 262 (7%) 116 (6%) 103 (6%)
Appendix Table 2
Incidence of Stroke Associated with Expanded Lesion 
Size Categories and Ordered by Prevalence
Though sample sizes were small in individual categories, Hazard Ratios appeared elevated 
whenever very small lesions (<3mm) were present.
Group <3 3–7 8–20 >20
Lesion
Group N (Prevalence) Stroke Hazard Ratios
1 Absent Absent Absent Absent No Lesions 1611 (86%) -ref-
2 Absent Present Absent Absent ≥3 only 84 (4.5%) 1.02 (0.46, 2.23) p=0.963
3 Present Absent Absent Absent <3 only 50 (2.7%) 3.50 (1.87, 6.55) p<0.001
4 Absent Absent Present Absent ≥3 only 47 (2.5%) 3.00 (1.43, 6.33) p=0.004
5 Absent Present Present Absent ≥3 only 27 (1.4%) 4.56 (2.04, 10.19) p<0.001
6 Absent Absent Absent Present ≥3 only 16 (0.9%) 0.86 (0.12, 6.24) p=0.878
7 Present Present Absent Absent Both 14 (0.7%) 14.76 (6.29, 34.60) 
p<0.001
8 Present Absent Present Absent Both 9 (0.5%) 8.85 (3.46, 22.61) p<0.001
9 Absent Present Absent Present ≥3 only 7 (0.4%) 3.22 (0.73, 14.13) p=0.121
10 Present Present Present Absent Both 6 (0.3%) 2.93 (0.40, 21.63) p=0.293
11 Absent Absent Present Present ≥3 only 3 (0.2%) -
12 Present Absent Absent Present Both 2 (0.1%) -
13 Present Present Absent Present Both 2 (0.1%) -
14 Present Present Present Present Both 2 (0.1%) -
15 Absent Present Present Present ≥3 only 1 (0.1%) -
16 Present Absent Present Present Both 0 (0.0%) -
Unable to estimate stroke hazard ratios for the sample sizes <6.
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Cumulative incidence of stroke and stroke mortality by lesion size and white matter 
hyperintensity (WMH) grade
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